Drug intelligence / Profile preview

R21 + AS01B

Development stage
Preclinical
Lead developer
University of Oxford
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

R21 + AS01B is a malaria vaccine formulation combining the R21 antigen with the AS01B adjuvant. R21 is a malaria vaccine candidate that targets the circumsporozoite protein (CSP) of the Plasmodium parasite, which blocks the parasite from entering the liver. The R21 component consists of virus-like particles built from scaffolding derived from the hepatitis B virus, with a high proportion of malaria protein antigen (CSP) on its surface. While R21 is more commonly paired with Matrix-M adjuvant in clinical trials, this specific formulation uses AS01B, which is a liposomal adjuvant containing the immunostimulants MPL and QS-21.

Other names
R21 + ASO1B-University of Oxford-malariaR21/AS01BR21 with AS01BR-21 with AS01BR 21 with AS01B
02

Targets

CSP (Circumsporozoite protein)

Beyond the preview

Go deeper on R21 + AS01B.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on R21 + AS01B.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call